Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
Butler, D.
and
Messiha, F.S.
1986.
Alcohol withdrawal and carbamazepine.
Alcohol,
Vol. 3,
Issue. 2,
p.
113.
Johnson, Gordon F.
1987.
Lithium in Depression: A Review of the Antidepressant and Prophylactic Effects of Lithium.
Australian & New Zealand Journal of Psychiatry,
Vol. 21,
Issue. 3,
p.
356.
Tobias, Carmelita R.
Turns, Danielle M.
Lippmann, Steven
Pary, Raymond
and
Embry, Charles K.
1988.
Psychiatric disorders in the elderly.
Postgraduate Medicine,
Vol. 83,
Issue. 1,
p.
313.
Elphick, M.
Lyons, F.
and
Cowen, P.J.
1988.
Low tolerability of carbamazepine in psychiatric patients may restrict its clinical usefulness.
Journal of Psychopharmacology,
Vol. 2,
Issue. 1,
p.
1.
Silverstone, Trevor
1989.
New Directions in Affective Disorders.
p.
495.
Elphick, Martin
1989.
Clinical issues in the use of carbamazepine in psychiatry: a review.
Psychological Medicine,
Vol. 19,
Issue. 3,
p.
591.
Post, Robert M.
1990.
Prophylaxis of Bipolar Affective Disorders.
International Review of Psychiatry,
Vol. 2,
Issue. 3-4,
p.
277.
Dose, M.
and
Emrich, H. M.
1990.
Kombination therapeutischer Strategien bei schizophrenen Erkrankungen.
p.
50.
Lapensèe, Michèle A.
1992.
A Review of Schizoaffective Disorder: II. Somatic Treatment*.
The Canadian Journal of Psychiatry,
Vol. 37,
Issue. 5,
p.
347.
Solomon, David A.
and
Bauer, Mark S.
1993.
Continuation and Maintenance Pharmacotherapy for Unipolar and Bipolar Mood Disorders.
Psychiatric Clinics of North America,
Vol. 16,
Issue. 3,
p.
515.
CALABRESE, JOSEPH R.
FATEMI, S. HOSSEIN
KUJAWA, MARY
and
WOYSHVILLE, MARK J.
1996.
Predictors of Response to Mood Stabilizers.
Journal of Clinical Psychopharmacology,
Vol. 16,
Issue. SUPPLEMENT 1,
p.
24S.
Leucht, S
McGrath, J
White, P
Kissling, W
and
Leucht, Stefan
2002.
Cochrane Database of Systematic Reviews.
Leucht, Stefan
Kissling, Werner
McGrath, John
White, Paul
and
Leucht, Stefan
2007.
Cochrane Database of Systematic Reviews.
Grunze, Heinz
Vieta, Eduard
Goodwin, Guy M.
Bowden, Charles
Licht, Rasmus W.
Möller, Hans-Jürgen
Kasper, Siegfried
WFSBP Task Force on Treatment Guide
Grunze, Heinz
Vieta, Eduard
Goodwin, Guy M.
Bowden, Charles
Licht, Rasmus W.
Möller, Hans-Jürgen
Kasper, Siegfried
and
WFSBP Task Force on Treatment Guide
2009.
The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2009 on the Treatment of Acute Mania.
The World Journal of Biological Psychiatry,
Vol. 10,
Issue. 2,
p.
85.
Grunze, Heinz
2011.
Bipolar Psychopharmacotherapy.
p.
61.
Grunze, Heinz
Vieta, Eduard
Goodwin, Guy M.
Bowden, Charles
Licht, Rasmus W.
Möller, Hans-Jürgen
and
Kasper, Siegfried
2013.
The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2012 on the long-term treatment of bipolar disorder.
The World Journal of Biological Psychiatry,
Vol. 14,
Issue. 3,
p.
154.
Leucht, Stefan
Helfer, Bartosz
Dold, Markus
Kissling, Werner
and
McGrath, John
2014.
Carbamazepine for schizophrenia.
Cochrane Database of Systematic Reviews,
Vol. 2014,
Issue. 5,
Berger, Michael
Lewitzka, Ute
and
Seemüller, Florian
2015.
Akutbehandlung manischer Episoden.
DNP - Der Neurologe und Psychiater,
Vol. 16,
Issue. 12,
p.
47.
Grunze, Anna
Amann, Benedikt L.
and
Grunze, Heinz
2021.
Efficacy of Carbamazepine and Its Derivatives in the Treatment of Bipolar Disorder.
Medicina,
Vol. 57,
Issue. 5,
p.
433.
eLetters
No eLetters have been published for this article.